Chemistry: analytical and immunological testing – Pregnancy or ovulation
Reexamination Certificate
2011-07-12
2011-07-12
Gabel, Gail R (Department: 1641)
Chemistry: analytical and immunological testing
Pregnancy or ovulation
C435S007100, C435S007940, C435S971000, C436S501000, C436S546000, C436S547000, C436S548000, C436S087000, C436S811000, C436S818000, C530S387500, C530S388240, C530S389200
Reexamination Certificate
active
07977104
ABSTRACT:
The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
REFERENCES:
patent: 4444879 (1984-04-01), Foster et al.
patent: 4514505 (1985-04-01), Canfield et al.
patent: 5260421 (1993-11-01), Chappel et al.
patent: 6133048 (2000-10-01), Penfold et al.
patent: 6339143 (2002-01-01), Krichevsky et al.
patent: 6429018 (2002-08-01), Cole et al.
patent: 6500627 (2002-12-01), O'Connor et al.
patent: 6927034 (2005-08-01), O'Connor et al.
patent: 7198954 (2007-04-01), O'Connor et al.
patent: 7285391 (2007-10-01), O'Connor et al.
patent: 7399636 (2008-07-01), O'Connor et al.
patent: 2003/0022381 (2003-01-01), Pandian et al.
patent: 2008/0108089 (2008-05-01), O'Connor et al.
patent: 04300896 (1992-10-01), None
patent: WO 88/04779 (1988-06-01), None
patent: WO 92/07272 (1992-04-01), None
patent: WO 99/41584 (1999-08-01), None
patent: WO 00/70094 (2000-12-01), None
U.S. Appl. No. 09/918,297, filed Jul. 30, 2001, Pandian, M.R. and Yu J.Y.
Acevedo, et al. (1992). Expression of Membrane-associated Human Chorionic Gonadotropin, Its Subunits, and Fragments by Cultured Human Cancer Cells. Cancer 69(7):1829-1842.
Berger, et al. (1993) Variants of Human Chorionic Gonadotropin from Pregnant Women and Tumor Patients Recognized by Monclonal Antibodies. J. Clin. Endocrin. Met. 77(2): 34.
Birken, et al. (1999) Development and Characterization of Antibodies to a Nicked and Hyperglycosylated Form of hCG from . . . Endocrinology 10(2):137-144.
Birken, et al. (1993) Separation of Nicked Human Chorionic Gonadotropin (hCG), Intact hCG, and hCGb Fragement from . . . Endocrinology 133:(3) 1390-1397.
Birken, et al. (1996). Metabolism of hCG and hLH to Multiple Urinary Forms Mol. Cell Endocrinol. 125:121-131.
Birken, et al. (1996). Isolation and Characterization of Human Pituitary Chorionic Gonadotropin. Endocrinology 137:1402-1411.
Bogart, M. et al. (1987) Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat. Diagn., 7(9):623-630.
Bogart, M. et al. (1989) Human Chorionic Gonadotropin Levels in Pregnancies with Aneuploid Fetuses. Prenat. Diagn., 9(6):379-384.
Cole, L. (1998) hCG, Its Free Subunits and Its Metabolites. Roles in Pregnancy and Trophoblastic Disease. J. Reprod. Med., 43(1):3-10.
Cole, L. et al. (1985) The Structures of the Serine-linked Sugar Chains on Human Chorionic Gonadotropin. Biochem. Biophys. Res. Commun., 126(1):333-339.
Cole, L. et al. (1991) The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological . . . Endocrinology, 129(3):1559-1567.
Cole, L. et al. (1993) The Deactivation of hCG by Nicking and Dissociation. J. Clin. Endocrinol. Metab., 76(3):704-710.
Cole, L. et al. (1997) Oligosaccharide Variants of hCG-Related Molecules: Potential Screening Markers for Down Syndrome. Prenat. Diagn., 17(12):1188-1190.
Cole, L. et al. (1997) Urine Beta-Core Fragment, a Potential Screening Test for Ectopic Pregnancy and Spontaneous Abortion. Fetal. Diagn. Ther., 12(6):336-339.
Cole, L. et al. (1998) Hyperglycosylated hCG, a Potential Alternative to hCG in Down Syndrome Screening. Prenat. Diagn.,18(9):926-933.
Ehrlich, P.H. and Moyle, W.R. (1983) Cooperative Immunoassays: Ultrasensitive Assays with Mixed Monoclonal Antibodies. Science. (4607):279-281.
Ehrlich, P.H. et al. (1982) Mixing Two Monoclonal Antibodies Yields Enhanced Affinity for Antigen. J. Immunol. 128(6):2709-13.
Ehrlich, P.H. et al. (1985) Characterization and Relative Orientation of Epitopes for Monoclonal Antibodies and Antisera to . . . Am. J. Reprod. Immunol. Microbiol. 8(2):48-54.
Ehrlich, P.H. et al. (1985) Monoclonal Antibodies to Gonadotropin Subunits. Methods Enzymol. 109:638-55.
Elliott, M.M. et al. (1997). Carbohydrate and Peptide Structure of the Alpha- and Beta-Subunits of Human Chorionic Gonadotropin from Normal and . . . Endocrine. 7(1):15-32.
Ellish, et al. (1996) A Prospective Study of Early Pregnancy Loss. Hum. Reprod. 11(2):406-412.
Forest, J. et al. (1995) Screening for Down Syndrome During the First and Second Trimesters: Impact of Risk Estimation Parameters. Clin. Biochem., 28(4):443-449.
Hoermann, et al. (1993) Molecular Heterogeneity of Human Chorionic Gonadotropin in Serum and Urine from Pateints with Trophoblastic Tumors. Clin. Chem. 71: 953-960.
Hoermann, et al. (1994). Immunological Recognition and Clinical Significance of Nicked Human Chorionic Gonadotropin in Testicular Cancer Clin. Chem. 40(12):2306-2312.
Huang, S. et al. J. (1988). A Chromatofocusing Study of Human Chorionic Gonadotropin in Biological Fluids in Normal Pregnancy . . . J. Formosan Medical Assn. 87(11):1036-1044.
Kardana, A. et al. (1991) The Heterogeneity of Human Chorionic Gonadotropin (hCG). I. Characterization of Peptide Heterogeneity in . . . Endocrinology 129(3):1541-50.
Knight, P. (1989) The Carbohydrate Frontier. Biotechnology 7(1): 35-36 and 39-40.
Kovalevskaya, et al. (1999) Early Pregnancy Human Chorionic Gonadotropin (hCG) Isoforms Measured by an Immunometric Assay for . . . J. Endocrinol. 161:99-106.
Kovalevskaya, et al. (1999) Evaluation of Nicked Human Chorionic Gonadotropin in Content in Clinical Specimens by a Psecific Immunometric Assay. Clin. Chem. 45(1):68-77.
Kovalevskaya, et al. (1995) HLH beta Core Fragment Immunoreactivity in the Urine of Ovulating Women: A Sensitive and Specific Immunometric Assay . . . Endocrine 3:881-887.
Kovalevskaya, G. et al. (2002) Differential Expression of Human Chorionic Gonadotropin (hCG) Glycosylation Isoforms in Failing and Continuing . . . J. Endocrin., 172(3):497-506.
O'Connor, et al. (1988) Development of Highly Sensitive Immunoassays to Measure Human Chorionic Gonadotropin, its b-subunit, and Core Fragment . . . Cancer Res. 48:1361-1366.
O'Connor, et al. (1994). Recent Advances in the Chemistry and Immunochemistry of Human Chorionic Gonadotropin: Impact of Clinical Measurements. Endocr. Rev. 15:650-683.
O'Connor, et al. (1998) Differential Urinary Gonadotrophin Profiles in Early Pregnancy and Early preganncy Loss. Prenatal Diagnosis 18(12):1232-1240.
Rau, B. et al. (1995) [Significance of Serum beta-hCG as a Tumor Marker for Stomach Carcinoma.] [Article in German] Langenbecks Arch. Chir., 380(6):359-64.
Spencer, K. et al. (1993) Stability of Intact Chorionic Gonadotropin (hCG) in Serum, Liquid Whole Blood, and Dried Whole-Blood . . . Clin. Chem.39(6):1064-1068.
Spencer, K. et al. (1996) Urine Free beta hCG and beta Core in Pregnancies Affected by Down's Syndrome. Prenat. Diagn. 16(7):605-613.
Spencer, K. et al. (1997) Biochemical Markers of Trisomy 21 in Amniotic Fluid. Prenat. Diagn.17(1):31-37.
Valerio, D. et al. (1996) Maternal Serum Screening of Fetal Chromosomal Abnormalities by AFP, UE3, hCG and Free-beta hCG . . . Minerva. Ginecol., 48(5):169-173.
Wald, N. et al. (1994) Four-Marker Serum Screening for Down's Syndrome. Prenat Diagn. 14(8):707-16.
Wald, N. et al. (1994) First Trimester Biochemical Screening for Down's Syndrome. Ann. Med. 26(1):23-29.
Wilcox, et al.(1988) Incidence of Early Loss of Pregnancy. N. Engl. J. Med. 319:189-194.
Zimmermann, R. et al. (1996) Age-Independent Indices in Second-Trimester Serum Screening for Down's Syndrome are Useless. Prenat. Diagn.16(1):79-82.
Zinaman, et al. (1996) Estimates of Human Fertility and Preganncy Loss. Fertil. Steril. 65:503-509.
International Search Report issued Sep. 13, 1999 in connection with PCT International Application No
Birken Steven
Kovalevskaya Galina I.
O'Connor John F.
Cooper & Dunham LLP
Gabel Gail R
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Methods for predicting pregnancy outcome in a subject by hCG... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for predicting pregnancy outcome in a subject by hCG..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for predicting pregnancy outcome in a subject by hCG... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2635921